3.04
-0.18(-5.59%)
Currency In USD
Address
2215 Yukon Street
Vancouver, BC V5Y 0A1
Canada
Phone
604 559 9005
Website
Sector
Healthcare
Industry
Biotechnology
Employees
596
First IPO Date
December 11, 2020
| Name | Title | Pay | Year Born |
| Carl Hansen | Chief Executive Officer, President & Chairperson | 746,836 | 1974 |
| Veronique Lecault | Chief Technology Officer & Director | 667,706 | 1984 |
| Andrew Booth | Chief Financial Officer | 671,720 | 1973 |
| Tryn T. Stimart | Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer | 685,080 | 1969 |
| Caitlin Webster | Director of Talent Development | 0 | N/A |
| Graham Craig | Director of Corporate Development | 0 | N/A |
| Janna Bednenko | Head of Protein Expression & Genetics | 0 | N/A |
| Marcie Thiessen | Senior Director of Finance & Accounting | 0 | N/A |
| Adam Clarke | Senior Vice President of Discovery | 0 | N/A |
| Andrew Knowles | VP of Operations | 0 | N/A |
| Murray McCutcheon | Senior Vice President of Partnering | 0 | N/A |
| Paul Colussi | Site Head & Vice President of Australia | 0 | N/A |
| Tiffany Chiu | Vice President of Communications | 0 | N/A |
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
